a,bKyle T. Amber, MD; bRomi Bloom, MD; bMohammad-Ali Yazdani Abyaneh, MD; bLeyre A. Falto-Aizpurua, MD; bMartha Viera, MD; cMartin N. Zaiac, MD; bKeyvan Nouri, MD; bShasa Hu, MD aDepartment of
aAnn M. John, MD; bElizabeth S. John, MD; cDavid R. Hansberry, MD, PhD; aWilliam Clark Lambert, MD, PhD aDepartment of Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey; bDepartment
aSandeep Mahapatra, MD; aDhruva Kumar, DDVL; bVignesh Subramanian, MSc; bSwarup K. Chakrabarti, PhD; bKaushik D. Deb, PhD aDerma Solutions Clinic, Bangalore, Karnataka, India; bDiponEd BioIntelligence LLP, Bangalore, Karnataka, India Disclosure:
aJessica A. Kaffenberger, MD; bJoy Mosser, MD; aGrace Lee, MD; aLlana Pootrakul, MD, PhD; bKatya Harfmann, MD; aStephanie Fabbro, MD; bEsteban Fernandez Faith, MD; aDavid Carr, MD; aAlisha Plotner, MD;
James Q. Del Rosso, DO; Leon Kircik, MD Disclosures (related to this manuscript): Dr. Del Rosso is a speaker, consultant, and/or researcher for Anacor, Aqua, Allergan, Bayer, Celgene, Galderma, LeoPharma,
